[HTML][HTML] Diabetic cardiomyopathy: Early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions

JL Huo, Q Feng, S Pan, WJ Fu, Z Liu, Z Liu - Cell death discovery, 2023 - nature.com
Diabetic cardiomyopathy (DCM) mainly refers to myocardial metabolic dysfunction caused
by high glucose, and hyperglycemia is an independent risk factor for cardiac function in the …

[HTML][HTML] Diabetic cardiomyopathy: where we are and where we are going

WS Lee, J Kim - The Korean journal of internal medicine, 2017 - ncbi.nlm.nih.gov
The global burden of diabetes mellitus and its related complications are currently increasing.
Diabetes mellitus affects the heart through various mechanisms including microvascular …

[HTML][HTML] Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management

JM Pappachan, GI Varughese, R Sriraman… - World journal of …, 2013 - ncbi.nlm.nih.gov
Diabetes affects every organ in the body and cardiovascular disease accounts for two-thirds
of the mortality in the diabetic population. Diabetes-related heart disease occurs in the form …

Mitochondrial NAD+/NADH Redox State and Diabetic Cardiomyopathy

JM Berthiaume, JG Kurdys, DM Muntean… - Antioxidants & Redox …, 2019 - liebertpub.com
Significance: Diabetic cardiomyopathy (DCM) is a frequent complication occurring even in
well-controlled asymptomatic diabetic patients, and it may advance to heart failure (HF) …

[HTML][HTML] Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation

K Gopal, QG Karwi, SA Tabatabaei Dakhili… - Cardiovascular …, 2023 - Springer
Background Cardiovascular diseases, including diabetic cardiomyopathy, are major causes
of death in people with type 2 diabetes. Aldose reductase activity is enhanced in …

Mechanisms of lipotoxicity in the cardiovascular system

AR Wende, JD Symons, ED Abel - Current hypertension reports, 2012 - Springer
Cardiovascular diseases account for approximately one third of all deaths globally. Obese
and diabetic patients have a high likelihood of dying from complications associated with …

Cardiac metabolism—a promising therapeutic target for heart failure

H Noordali, BL Loudon, MP Frenneaux… - Pharmacology & …, 2018 - Elsevier
Both heart failure with reduced ejection fraction (HFrEF) and with preserved ejection fraction
(HFpEF) are associated with high morbidity and mortality. Although many established …

[HTML][HTML] Lean heart: role of leptin in cardiac hypertrophy and metabolism

ME Hall, R Harmancey, DE Stec - World journal of cardiology, 2015 - ncbi.nlm.nih.gov
Leptin is an adipokine that has been linked with the cardiovascular complications resulting
from obesity such as hypertension and heart disease. Obese patients have high levels of …

Trimetazidine in heart failure with preserved ejection fraction: a randomized controlled cross‐over trial

AA van de Bovenkamp, KTJ Geurkink… - ESC heart …, 2023 - Wiley Online Library
Aims Impaired myocardial energy homeostasis plays an import role in the pathophysiology
of heart failure with preserved ejection fraction (HFpEF). Left ventricular relaxation has a …

Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart

RM Singh, T Waqar, FC Howarth, E Adeghate… - Heart failure …, 2018 - Springer
The development of a diabetic cardiomyopathy is a multifactorial process, and evidence is
accumulating that defects in intracellular free calcium concentration [Ca 2+] i or its …